Team:Melbourne/Safety

From 2014.igem.org

(Difference between revisions)
Line 522: Line 522:
<h1 >University of Melbourne<br>
<h1 >University of Melbourne<br>
  iGEM team </h1>
  iGEM team </h1>
-
<p>Welcome, from the team at the University of Melbourne, Australia<br>
+
<ol>
-
<br>Contact us via email at melbourneuniigem@gmail.com<br>
+
  <li><strong>Safety  Level Rating System</strong></li>
-
</p>
+
<p> Australia uses a four-part &lsquo;Safety  Level&rsquo; rating system for laboratories in which Level 4 is used for the most dangerous organisms. Our laboratory is Level 2 (moderate risk).</p>
-
<!-- INSERT YOUR CONTENT HERE -->
+
<p>&nbsp;</p>
-
<br>
+
-
1. Safety Level Rating System
+
-
<br>
+
-
Australia uses a four-part ‘Safety Level’ rating system for laboratories in which Level 4 is used for the most dangerous organisms. Our laboratory is Level 2 (moderate risk).
+
-
<br><br>
+
  <li><strong>Work Environments Used to Handle Biological Materials</strong></li>
-
2. Work Environments Used to Handle Biological Materials
+
-
<br>
+
-
Open benches and a laminar flow hood/biosafety cabinet with open front are used when handling biological materials in our laboratory.<br>
+
-
Some materials are handled in different work environments, for example DNA gels containing EtBr are only used in designated areas and some procedures involving bacteria that need to be sterile are performed near an open flame, while most other procedures are performed at open benches.
+
<p>Open benches and a laminar flow  hood/biosafety cabinet with open front are used when handling biological  materials in our laboratory.</p>
 +
<p>Some materials are handled in different work environments, for example DNA gels containing EtBr are only used in designated areas and some procedures involving bacteria that need to be sterile are performed near an open flame, while most other procedures are performed at open benches.</p>
 +
<p>&nbsp;</p>
-
<br><br>
+
  <li><strong>Personal Protective Equipment</strong></li>
-
3. Personal Protective Equipment
+
-
<br>
+
-
In our laboratory lab coats, gloves and safety glasses/goggles are worn at all times and full face shields are worn when using the UV light box. Latex gloves are used for most procedures in the lab, however, nitrile gloves are worn when handling EtBr.
+
-
<br><br>
+
<p>In our laboratory lab coats, gloves  and safety glasses/goggles are worn at all times and full face shields are worn  when using the UV light box. Latex gloves are used for most procedures in the  lab, however, nitrile gloves are worn when handling EtBr.</p>
-
4. Disposal of Biological Waste
+
<p>&nbsp;</p>
-
<br>
+
 
-
Biological waste (e.g. pipette tips) are disposed of in a yellow biohazard which is sealed when not in use. When full, this biohazard bin is sent to be autoclaved before it is disposed with appropriately along with the biological waste from the other laboratories in the institute.<br>
+
  <li><strong>Disposal of Biological Waste</strong></li>
 +
 
 +
<p>Biological waste (e.g. pipette tips) are disposed of in a yellow biohazard which is sealed when not in use. When full, this biohazard bin is sent to be autoclaved before it is disposed with appropriately along with the biological waste from the other laboratories in the institute.</p>
 +
<p>Biological waste such as liquid cell  cultures has bleach added to it and sits overnight in the fume cabinet before  the liquid is poured down a special biological waste drain and the container is  autoclaved.</p>
 +
 
 +
  <li><strong>Safety  Training</strong></li>
 +
 
 +
<p><strong>&nbsp;</strong></p>
 +
<p>The Melbourne iGEM team received  safety training provided by The Bio21 Institute. The topics covered in this  training included: details of emergency actions, the university OH&amp;S policy  and issue resolution procedures, the university's environment policy and  procedures, procedures for reporting incidents/near misses, hazards and unsafe  acts/work processes, introduction to Bio21 EHS staff, location of relevant EHS  documentation, security, 'out of normal hours' access, equipment operating  procedures, general safety.</p>
 +
<p>The laboratory safety requirements of  the institution can be found here: <a href="https://intranet.mdhs.unimelb.edu.au/ohse-training-requirements">https://intranet.mdhs.unimelb.edu.au/ohse-training-requirements</a>.<br>
 +
</p>
-
Biological waste such as liquid cell cultures has bleach added to it and sits overnight in the fume cabinet before the liquid is poured down a special biological waste drain and the container is autoclaved.
+
  <li><strong>Local  Rules and Regulations</strong></li>
-
<br><br>
+
-
5. Safety Training
+
-
<br>
+
-
The Melbourne iGEM team received safety training provided by The Bio21 Institute. The topics covered in this training included: details of emergency actions, the university OH&S policy and issue resolution procedures, the university's environment policy and procedures, procedures for reporting incidents/near misses, hazards and unsafe acts/work processes, introduction to Bio21 EHS staff, location of relevant EHS documentation, security, 'out of normal hours' access, equipment operating procedures, general safety.<br>
+
-
The laboratory safety requirements of the institution can be found here: https://intranet.mdhs.unimelb.edu.au/ohse-training-requirements.<br>
+
<p>Christian Rantzau (Bio21 Health &amp;  Safety Representative) is responsible for biological safety at our institution. We briefly discussed the program with him and no concerns were raised, nor changes made to the project. He ensured that we were appropriately trained in the safety protocols and procedures of the institution.</p>
-
<br>
+
<p>The biosafety guidelines of The Bio21  Institute can be found at: <a href="http://www.bio21.unimelb.edu.au/bio-21-institute-intranet/environmental-health-and-safety/safety">http://www.bio21.unimelb.edu.au/bio-21-institute-intranet/environmental-health-and-safety/safety</a>.</p>
-
6. Local Rules and Regulations
+
<p>The regulations that govern biosafety  in research laboratories in Australia may be found via the following link: <a href="http://www.ogtr.gov.au/internet/ogtr/publishing.nsf/Content/legislation-2">http://www.ogtr.gov.au/internet/ogtr/publishing.nsf/Content/legislation-2</a>.</p>
-
<br>
+
-
Christian Rantzau (Bio21 Health & Safety Representative) is responsible for biological safety at our institution. We briefly discussed the program with him and no concerns were raised, nor changes made to the project. He ensured that we were appropriately trained in the safety protocols and procedures of the institution.<br>
+
-
The biosafety guidelines of The Bio21 Institute can be found at: http://www.bio21.unimelb.edu.au/bio-21-institute-intranet/environmental-health-and-safety/safety.<br>
+
  <li><strong>Organisms  and Parts Used</strong></li>
-
The regulations that govern biosafety in research laboratories in Australia may be found via the following link: http://www.ogtr.gov.au/internet/ogtr/publishing.nsf/Content/legislation-2.
+
<p>&nbsp;</p>
-
<br><br>
+
<table border="1" cellspacing="0" cellpadding="0" width="123%">
-
7. Organisms and Parts Used
+
  <tr>
-
<br>
+
    <td width="21%" nowrap valign="bottom"><p><strong>Species Name</strong></p></td>
-
Species Name: E. coli, BL21(DE3) <br>
+
    <td width="4%" nowrap valign="bottom"><p><strong>Risk Group</strong></p></td>
-
Risk Group: 1 <br>
+
    <td width="6%" nowrap valign="bottom"><p><strong>Risk Group Source</strong></p></td>
-
Risk Group Source: E. coli K12 <br>
+
    <td width="10%" nowrap valign="bottom"><p><strong>Disease risk to humans?</strong></p></td>
-
Disease risk to humans?: Very low virulence <br>
+
    <td width="15%" nowrap valign="bottom"><p><strong>Part number/name</strong></p></td>
-
Part number/name: <br>
+
    <td width="9%" nowrap valign="bottom"><p><strong>Natural function of part</strong></p></td>
-
Natural function of part: <br>
+
    <td width="14%" nowrap valign="bottom"><p><strong>How did you acquire it?</strong></p></td>
-
How did you acquire it?: Donation from neighboring lab <br>
+
    <td width="17%" nowrap valign="bottom"><p>How will you use it?</p></td>
-
How will you use it?: This is one of our chassis <br>
+
  </tr>
-
<br>
+
  <tr>
-
Species Name: E. coli, SHuffle T7 commercially available cells <br>
+
    <td width="21%" nowrap valign="bottom"><p>E. coli, BL21(DE3)</p></td>
-
Risk Group: 1 <br>
+
    <td width="4%" nowrap valign="bottom"><p align="right">1</p></td>
-
Risk Group Source: E. coli B <br>
+
    <td width="6%" nowrap valign="bottom"><p>E. coli K12</p></td>
-
Disease risk to humans?: Very low virulence <br>
+
    <td width="10%" nowrap valign="bottom"><p>Very low virulence</p></td>
-
Part number/name: <br>
+
    <td width="15%" nowrap valign="bottom"></td>
-
Natural function of part: <br>
+
    <td width="9%" nowrap valign="bottom"></td>
-
How did you acquire it?: Acquired from local New England Biolabs agent <br>
+
    <td width="14%" nowrap valign="bottom"><p>Donation from neighboring lab</p></td>
-
How will you use it?: This is one of our chassis <br>
+
    <td width="17%" nowrap valign="bottom"><p>This is one of our chassis</p></td>
-
<br>
+
  </tr>
-
Species Name: <br>
+
  <tr>
-
Risk Group: <br>
+
    <td width="21%" nowrap valign="bottom"><p>E. coli, SHuffle T7 commercially   available cells</p></td>
-
Risk Group Source: <br>
+
    <td width="4%" nowrap valign="bottom"><p align="right">1</p></td>
-
Disease risk to humans?: <br>
+
    <td width="6%" nowrap valign="bottom"><p>E. coli B</p></td>
-
Part number/name: Synthetic peptide 1 based on a de novo amino acid sequence <br>
+
    <td width="10%" nowrap valign="bottom"><p>Very low virulence</p></td>
-
Natural function of part: Not natural <br>
+
    <td width="15%" nowrap valign="bottom"></td>
-
How did you acquire it?: Designed DNA from scratch; DNA synthesised by Life Technologies <br>
+
    <td width="9%" nowrap valign="bottom"></td>
-
How will you use it?: <br>
+
    <td width="14%" nowrap valign="bottom"><p>Acquired from local New England Biolabs   agent</p></td>
-
<br>
+
    <td width="17%" nowrap valign="bottom"><p>This is one of our chassis</p></td>
-
Species Name: <br>
+
  </tr>
-
Risk Group: <br>
+
  <tr>
-
Risk Group Source: <br>
+
    <td width="21%" nowrap valign="bottom"></td>
-
Disease risk to humans?: <br>
+
    <td width="4%" nowrap valign="bottom"></td>
-
Part number/name: Synthetic peptide 2 based on a de novo amino acid sequence <br>
+
    <td width="6%" nowrap valign="bottom"></td>
-
Natural function of part: Not natural <br>
+
    <td width="10%" nowrap valign="bottom"></td>
-
How did you acquire it?: Designed DNA from scratch; DNA synthesised by Life Technologies <br>
+
    <td width="15%" nowrap valign="bottom"><p>Synthetic peptide 1 based on a de novo   amino acid sequence</p></td>
-
How will you use it?: <br>
+
    <td width="9%" nowrap valign="bottom"><p>Not natural</p></td>
-
<br>
+
    <td width="31%" nowrap colspan="2" valign="bottom"><p>Designed DNA from scratch; DNA   synthesised by Life Technologies</p></td>
-
Species Name: <br>
+
  </tr>
-
Risk Group: <br>
+
  <tr>
-
Risk Group Source: <br>
+
    <td width="21%" nowrap valign="bottom"></td>
-
Disease risk to humans?: <br>
+
    <td width="4%" nowrap valign="bottom"></td>
-
Part number/name: Synthetic peptide 3 based on a de novo amino acid sequence <br>
+
    <td width="6%" nowrap valign="bottom"></td>
-
Natural function of part: Not natural <br>
+
    <td width="10%" nowrap valign="bottom"></td>
-
How did you acquire it?: Designed DNA from scratch; DNA synthesised by Life Technologies <br>
+
    <td width="15%" nowrap valign="bottom"><p>Synthetic peptide 2 based on a de novo   amino acid sequence</p></td>
-
How will you use it?: <br>
+
    <td width="9%" nowrap valign="bottom"><p>Not natural</p></td>
-
<br>
+
    <td width="31%" nowrap colspan="2" valign="bottom"><p>Designed DNA from scratch; DNA   synthesised by Life Technologies</p></td>
-
Species Name: <br>
+
  </tr>
-
Risk Group: <br>
+
  <tr>
-
Risk Group Source: <br>
+
    <td width="21%" nowrap valign="bottom"></td>
-
Disease risk to humans?: <br>
+
    <td width="4%" nowrap valign="bottom"></td>
-
Part number/name: Synthetic peptide 4 based on a de novo amino acid sequence <br>
+
    <td width="6%" nowrap valign="bottom"></td>
-
Natural function of part: Not natural <br>
+
    <td width="10%" nowrap valign="bottom"></td>
-
How did you acquire it?: Designed DNA from scratch; DNA synthesised by Life Technologies <br>
+
    <td width="15%" nowrap valign="bottom"><p>Synthetic peptide 3 based on a de novo   amino acid sequence</p></td>
-
How will you use it?: <br>
+
    <td width="9%" nowrap valign="bottom"><p>Not natural</p></td>
-
<br>
+
    <td width="31%" nowrap colspan="2" valign="bottom"><p>Designed DNA from scratch; DNA   synthesised by Genscript</p></td>
-
Species Name: <br>
+
  </tr>
-
Risk Group: <br>
+
  <tr>
-
Risk Group Source: <br>
+
    <td width="21%" nowrap valign="bottom"></td>
-
Disease risk to humans?: <br>
+
    <td width="4%" nowrap valign="bottom"></td>
-
Part number/name: Synthetic peptide 5 based on a de novo amino acid sequence <br>
+
    <td width="6%" nowrap valign="bottom"></td>
-
Natural function of part: Not natural <br>
+
    <td width="10%" nowrap valign="bottom"></td>
-
How did you acquire it?: Designed DNA from scratch; DNA synthesised by Life Technologies <br>
+
    <td width="15%" nowrap valign="bottom"><p>Synthetic peptide 4 based on a de novo   amino acid sequence</p></td>
-
How will you use it?: <br>
+
    <td width="9%" nowrap valign="bottom"><p>Not natural</p></td>
-
<br>
+
    <td width="31%" nowrap colspan="2" valign="bottom"><p>Designed DNA from scratch; DNA   synthesised by Genscript</p></td>
-
Species Name: <br>
+
  </tr>
-
Risk Group: <br>
+
  <tr>
-
Risk Group Source: <br>
+
    <td width="21%" nowrap valign="bottom"></td>
-
Disease risk to humans?: <br>
+
    <td width="4%" nowrap valign="bottom"></td>
-
Part number/name: TEV protease gene <br>
+
    <td width="6%" nowrap valign="bottom"></td>
-
Natural function of part: Tobacco etch virus protease <br>
+
    <td width="10%" nowrap valign="bottom"></td>
-
How did you acquire it?: Donation from neighboring lab <br>
+
    <td width="15%" nowrap valign="bottom"><p>Synthetic peptide 5 based on a de novo   amino acid sequence</p></td>
-
How will you use it?:
+
    <td width="9%" nowrap valign="bottom"><p>Not natural</p></td>
 +
    <td width="31%" nowrap colspan="2" valign="bottom"><p>Designed DNA from scratch; DNA   synthesised by Genscript</p></td>
 +
  </tr>
 +
  <tr>
 +
    <td width="21%" nowrap valign="bottom"></td>
 +
    <td width="4%" nowrap valign="bottom"></td>
 +
    <td width="6%" nowrap valign="bottom"></td>
 +
    <td width="10%" nowrap valign="bottom"></td>
 +
    <td width="15%" nowrap valign="bottom"><p>TEV protease gene</p></td>
 +
    <td width="9%" nowrap valign="bottom"><p>Tobacco etch virus protease</p></td>
 +
    <td width="31%" nowrap colspan="2" valign="bottom"><p>Donation from neighboring lab</p></td>
 +
  </tr>
 +
</table>
 +
<p><strong>Risks  of Our Project Now</strong></p>
-
<br><br>
+
<p><u>Risk to the Safety and Health of Team Members/People Working in the Lab</u><br>
-
8. Risks of Our Project Now
+
  <em>E. coli</em> has a low, but not non-existent virulence. For this reason, we wear gloves and lab coats and wash our hands when entering and leaving the labs. When analysing DNA agarose gels both the EtBr solution and the UV light box pose a risk to the health of our team members. In these specific cases we wear nitrile gloves when handling the gel and a face shield when operating the light box.</p>
-
<br>
+
<p><u>Risk to the Safety and Health of the General Public</u><br>
-
Risk to the Safety and Health of Team Members/People Working in the Lab<br>
+
  <em>E. coli</em> has a low, but not non-existent virulence. For this reason, we wear gloves and lab coats and wash our hands when entering and leaving the labs. This helps to reduce the risk to the safety and health of the general public.</p>
-
E. coli has a low, but not non-existent virulence. For this reason, we wear gloves and lab coats and wash our hands when entering and leaving the labs. When analysing DNA agarose gels both the EtBr solution and the UV light box pose a risk to the health of our team members. In these specific cases we wear nitrile gloves when handling the gel and a face shield when operating the light box.<br>
+
<p><u>Risk to the Environment</u><br>
-
<br>
+
  When disposing of things such as liquid cell culture, we sit them overnight in the fume cabinet with some bleach in the,. In the morning we then pour the liquid down the shoot in the fume cabinet and autoclave the containers. We do not pour hazardous chemicals down the sink. All of these action minimise the risks to the environment.</p>
-
Risk to the Safety and Health of the General Public<br>
+
<p><u>Risks to Security Through Malicious Mis-Use</u><br>
-
E. coli has a low, but not non-existent virulence. For this reason, we wear gloves and lab coats and wash our hands when entering and leaving the labs. This helps to reduce the risk to the safety and health of the general public.<br>
+
  Our project does not pose much of a risk in terms of malicious mis-use by others, but to try and prevent this we have key card access into both the building and the labs so that they cannot be accessed by the general public.</p>
-
<br>
+
<p><u>Measures Taken to Reduce Risks</u><br>
-
Risk to the Environment<br>
+
  We employ safe lab practices (i.e. wearing gloves and lab coats), dispose of waste appropriately, use a baceterium (<em>E. coli</em>) with a very low virulence, and have key card access to the labs.</p>
-
When disposing of things such as liquid cell culture, we sit them overnight in the fume cabinet with some bleach in the,. In the morning we then pour the liquid down the shoot in the fume cabinet and autoclave the containers. We do not pour hazardous chemicals down the sink. All of these action minimise the risks to the environment.<br>
+
<p>&nbsp;</p>
-
<br>
+
-
Risks to Security Through Malicious Mis-Use<br>
+
-
Our project does not pose much of a risk in terms of malicious mis-use by others, but to try and prevent this we have key card access into both the building and the labs so that they cannot be accessed by the general public.<br>
+
-
<br>
+
-
Measures Taken to Reduce Risks<br>
+
-
We employ safe lab practices (i.e. wearing gloves and lab coats), dispose of waste appropriately, use a baceterium (E. coli) with a very low virulence, and have key card access to the labs.
+
-
<br><br>
+
-
9. Risks of Our Project in the Future
+
-
<br>
+
-
If our project is successful it will allow people to use the molecules we make as a platform technology for making disulphide bonded peptides. These peptides could potentially be used for harmful purposes. We don’t currently have any design features to reduce the risk of someone using our project for harmful purposes. In the future if it were deemed necessary we could potentially try to limit the types of amino residues or groups that could be added to the arms of our peptide by native chemical ligation.<br>
+
 +
  <li><strong>Risks  of Our Project in the Future</strong>
 +
    <p>If our project is successful it will  allow people to use the molecules we make as a platform technology for making  disulphide bonded peptides. These peptides could potentially be used for  harmful purposes. We don&rsquo;t currently have any design features to reduce the  risk of someone using our project for harmful purposes. In the future if it  were deemed necessary we could potentially try to limit the types of amino  residues or groups that could be added to the arms of our peptide by native  chemical ligation.</p>
 +
  </li>
 +
</ol>
<!-- END EDIT HERE HERE -->
<!-- END EDIT HERE HERE -->
</html>
</html>

Revision as of 11:32, 16 October 2014

Home Team Official Team Profile Project Parts Modeling Notebook Safety Attributions

University of Melbourne
iGEM team

  1. Safety Level Rating System
  2. Australia uses a four-part ‘Safety Level’ rating system for laboratories in which Level 4 is used for the most dangerous organisms. Our laboratory is Level 2 (moderate risk).

     

  3. Work Environments Used to Handle Biological Materials
  4. Open benches and a laminar flow hood/biosafety cabinet with open front are used when handling biological materials in our laboratory.

    Some materials are handled in different work environments, for example DNA gels containing EtBr are only used in designated areas and some procedures involving bacteria that need to be sterile are performed near an open flame, while most other procedures are performed at open benches.

     

  5. Personal Protective Equipment
  6. In our laboratory lab coats, gloves and safety glasses/goggles are worn at all times and full face shields are worn when using the UV light box. Latex gloves are used for most procedures in the lab, however, nitrile gloves are worn when handling EtBr.

     

  7. Disposal of Biological Waste
  8. Biological waste (e.g. pipette tips) are disposed of in a yellow biohazard which is sealed when not in use. When full, this biohazard bin is sent to be autoclaved before it is disposed with appropriately along with the biological waste from the other laboratories in the institute.

    Biological waste such as liquid cell cultures has bleach added to it and sits overnight in the fume cabinet before the liquid is poured down a special biological waste drain and the container is autoclaved.

  9. Safety Training
  10.  

    The Melbourne iGEM team received safety training provided by The Bio21 Institute. The topics covered in this training included: details of emergency actions, the university OH&S policy and issue resolution procedures, the university's environment policy and procedures, procedures for reporting incidents/near misses, hazards and unsafe acts/work processes, introduction to Bio21 EHS staff, location of relevant EHS documentation, security, 'out of normal hours' access, equipment operating procedures, general safety.

    The laboratory safety requirements of the institution can be found here: https://intranet.mdhs.unimelb.edu.au/ohse-training-requirements.

  11. Local Rules and Regulations
  12. Christian Rantzau (Bio21 Health & Safety Representative) is responsible for biological safety at our institution. We briefly discussed the program with him and no concerns were raised, nor changes made to the project. He ensured that we were appropriately trained in the safety protocols and procedures of the institution.

    The biosafety guidelines of The Bio21 Institute can be found at: http://www.bio21.unimelb.edu.au/bio-21-institute-intranet/environmental-health-and-safety/safety.

    The regulations that govern biosafety in research laboratories in Australia may be found via the following link: http://www.ogtr.gov.au/internet/ogtr/publishing.nsf/Content/legislation-2.

  13. Organisms and Parts Used
  14.  

    Species Name

    Risk Group

    Risk Group Source

    Disease risk to humans?

    Part number/name

    Natural function of part

    How did you acquire it?

    How will you use it?

    E. coli, BL21(DE3)

    1

    E. coli K12

    Very low virulence

    Donation from neighboring lab

    This is one of our chassis

    E. coli, SHuffle T7 commercially available cells

    1

    E. coli B

    Very low virulence

    Acquired from local New England Biolabs agent

    This is one of our chassis

    Synthetic peptide 1 based on a de novo amino acid sequence

    Not natural

    Designed DNA from scratch; DNA synthesised by Life Technologies

    Synthetic peptide 2 based on a de novo amino acid sequence

    Not natural

    Designed DNA from scratch; DNA synthesised by Life Technologies

    Synthetic peptide 3 based on a de novo amino acid sequence

    Not natural

    Designed DNA from scratch; DNA synthesised by Genscript

    Synthetic peptide 4 based on a de novo amino acid sequence

    Not natural

    Designed DNA from scratch; DNA synthesised by Genscript

    Synthetic peptide 5 based on a de novo amino acid sequence

    Not natural

    Designed DNA from scratch; DNA synthesised by Genscript

    TEV protease gene

    Tobacco etch virus protease

    Donation from neighboring lab

    Risks of Our Project Now

    Risk to the Safety and Health of Team Members/People Working in the Lab
    E. coli has a low, but not non-existent virulence. For this reason, we wear gloves and lab coats and wash our hands when entering and leaving the labs. When analysing DNA agarose gels both the EtBr solution and the UV light box pose a risk to the health of our team members. In these specific cases we wear nitrile gloves when handling the gel and a face shield when operating the light box.

    Risk to the Safety and Health of the General Public
    E. coli has a low, but not non-existent virulence. For this reason, we wear gloves and lab coats and wash our hands when entering and leaving the labs. This helps to reduce the risk to the safety and health of the general public.

    Risk to the Environment
    When disposing of things such as liquid cell culture, we sit them overnight in the fume cabinet with some bleach in the,. In the morning we then pour the liquid down the shoot in the fume cabinet and autoclave the containers. We do not pour hazardous chemicals down the sink. All of these action minimise the risks to the environment.

    Risks to Security Through Malicious Mis-Use
    Our project does not pose much of a risk in terms of malicious mis-use by others, but to try and prevent this we have key card access into both the building and the labs so that they cannot be accessed by the general public.

    Measures Taken to Reduce Risks
    We employ safe lab practices (i.e. wearing gloves and lab coats), dispose of waste appropriately, use a baceterium (E. coli) with a very low virulence, and have key card access to the labs.

     

  15. Risks of Our Project in the Future

    If our project is successful it will allow people to use the molecules we make as a platform technology for making disulphide bonded peptides. These peptides could potentially be used for harmful purposes. We don’t currently have any design features to reduce the risk of someone using our project for harmful purposes. In the future if it were deemed necessary we could potentially try to limit the types of amino residues or groups that could be added to the arms of our peptide by native chemical ligation.